These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10482469)

  • 1. Reactivation of herpes virus after lamellar keratoplasty.
    Zheng X; Loutsch JM; Shimomura Y; Gebhardt BM; Hill JM; Kaufman HE
    Jpn J Ophthalmol; 1999; 43(4):257-61. PubMed ID: 10482469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation and donor-host transmission of herpes simplex virus after corneal transplantation.
    Zheng X
    Cornea; 2002 Oct; 21(7 Suppl):S90-3. PubMed ID: 12484706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
    Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large Amounts of Reactivated Virus in Tears Precedes Recurrent Herpes Stromal Keratitis in Stressed Rabbits Latently Infected with Herpes Simplex Virus.
    Perng GC; Osorio N; Jiang X; Geertsema R; Hsiang C; Brown D; BenMohamed L; Wechsler SL
    Curr Eye Res; 2016; 41(3):284-91. PubMed ID: 25859798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.
    BenMohamed L; Osorio N; Khan AA; Srivastava R; Huang L; Krochmal JJ; Garcia JM; Simpson JL; Wechsler SL
    Curr Eye Res; 2016 Jun; 41(6):747-56. PubMed ID: 26398722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits.
    Hill JM; Garza HH; Helmy MF; Cook SD; Osborne PA; Johnson EM; Thompson HW; Green LC; O'Callaghan RJ; Gebhardt BM
    J Neurovirol; 1997 Jun; 3(3):206-11. PubMed ID: 9200068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo.
    Stroop WG; Banks MC; Qavi H; Chodosh J; Brown SM
    J Med Virol; 1994 Jul; 43(3):297-309. PubMed ID: 7931192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
    Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
    Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease.
    Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1163-70. PubMed ID: 9620075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent ocular herpes simplex keratitis following excimer laser photorefractive keratectomy in a rabbit model.
    Epstein SP; Fisher EM; Sternberg GJ; Franklin W; Gordon R; Ho JJ; Asbell PA
    CLAO J; 2001 Apr; 27(2):94-9. PubMed ID: 11352456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent herpes simplex after corneal transplantation in rats.
    Nicholls SM; Shimeld C; Easty DL; Hill TJ
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):425-35. PubMed ID: 8603848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits.
    Nesburn AB; Burke RL; Ghiasi H; Slanina S; Bahri S; Wechsler SL
    J Virol; 1994 Aug; 68(8):5084-92. PubMed ID: 8035508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine applied by transdermal patch induced HSV-1 reactivation and ocular shedding in latently infected rabbits.
    Myles ME; Alack C; Manino PM; Reish ER; Higaki S; Maruyama K; Mallakin A; Azcuy A; Barker S; Ragan FA; Thompson H; Hill JM
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):121-33. PubMed ID: 12804057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrating keratoplasty in rabbits induces latent HSV-1 reactivation when corticosteroids are used.
    Beyer CF; Arens MQ; Hill JM; Rose BT; Hill GA; Lin DT
    Curr Eye Res; 1989 Dec; 8(12):1323-9. PubMed ID: 2560694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular reactivation phenotype of HSV-1 strain F(MP)E, a corticosteroid-sensitive strain.
    Marquart M; Bhattacharjee P; Zheng X; Kaufman H; Thompson H; Varnell E; Hill J
    Curr Eye Res; 2003; 26(3-4):205-9. PubMed ID: 12815548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models.
    Gordon YJ; Yates KA; Mah FS; Romanowski EG
    J Ocul Pharmacol Ther; 2003 Jun; 19(3):233-45. PubMed ID: 12828841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iontophoresis of lysophosphatidic acid into rabbit cornea induces HSV-1 reactivation: evidence that neuronal signaling changes after infection.
    Martin RE; Loutsch JM; Garza HH; Boedeker DJ; Hill JM
    Mol Vis; 1999 Dec; 5():36. PubMed ID: 10617773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus.
    Stroop WG; Schaefer DC
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):229-37. PubMed ID: 8591901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular HSV-1 latency, reactivation and recurrent disease.
    Toma HS; Murina AT; Areaux RG; Neumann DM; Bhattacharjee PS; Foster TP; Kaufman HE; Hill JM
    Semin Ophthalmol; 2008; 23(4):249-73. PubMed ID: 18584563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.